TOKYO -- A dengue fever vaccine developed by Japan's Takeda Pharmaceutical has completed clinical trials and is expected to be approved in Indonesia soon, Nikkei has learned.
Pharmaceuticals
Takeda to sell dengue vaccine abroad, starting with Indonesia
Japan's first global vaccine can be used for children younger than existing shots
Takeda is investing 130 million euros ($132 million) to build a plant in Germany that can make 50 million doses of its dengue vaccine a year. (Photo courtesy of the company)
Read Next
Latest on Pharmaceuticals
